- Home
- FDMT vs CYRX Comparison
FDMT vs CYRX Comparison
Compare FDMT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | CYRX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.6M | 421.6M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FDMT | CYRX |
|---|---|---|
| Price | $8.71 | $8.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $34.13 | $12.94 |
| AVG Volume (30 Days) | ★ 725.8K | 358.4K |
| Earning Date | 04-13-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | $37,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $21,227.03 | $9.71 |
| Revenue Next Year | $161.87 | $9.56 |
| P/E Ratio | ★ N/A | $5.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $4.63 |
| 52 Week High | $12.34 | $11.45 |
Technical Indicators
Market Signals| Indicator | FDMT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 37.93 |
| Support Level | $8.11 | $6.57 |
| Resistance Level | $8.80 | $8.45 |
| Average True Range (ATR) | 0.57 | 0.50 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 20.96 | 27.14 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.